Launch of Next-Generation Ultrasonic Surgical System
Introducing the UltraSonic Pro 3000
After three years of intensive R&D and extensive clinical validation, SGO Medical is proud to introduce the UltraSonic Pro 3000 — our most advanced ultrasonic surgical system to date. This next-generation platform incorporates breakthrough Adaptive Tissue Technology (ATT) that automatically optimizes energy delivery based on real-time tissue characterization.
Revolutionary Adaptive Tissue Technology
The ATT system utilizes proprietary impedance sensing algorithms to continuously analyze tissue properties during activation. This intelligent feedback loop enables the system to:
- Automatically adjust ultrasonic amplitude based on tissue density
- Optimize cutting speed versus hemostasis balance in real-time
- Provide audible and visual feedback when optimal seal quality is achieved
- Reduce thermal spread to less than 1mm lateral — the lowest in the industry
Enhanced Performance Specifications
The UltraSonic Pro 3000 delivers measurable improvements over its predecessor and competitive systems:
- Vessel sealing capacity increased to 7mm (from 5mm in previous generation)
- Burst pressure exceeding 900mmHg (300mmHg above regulatory requirements)
- 50% reduction in jaw activation force for reduced surgeon hand fatigue
- 90% less surgical smoke generation compared to monopolar electrosurgery
Clinical Validation
Pre-market clinical studies involving 500 patients across 15 surgical centers in China, Germany, and the United States demonstrated statistically significant improvements in operative time (-18%), estimated blood loss (-25%), and postoperative pain scores (-22%) compared to the leading competitive ultrasonic platform.
